Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: Jim Bishop who wrote (14360)	11/16/1999 2:07:00 AM
From: CIMA	Respond to of 150070

WIZZF - OTC:BB Check this out! RB shareholders are into WIZZF in a huge way! PLATINUM LIST - FLOAT IS GONE BABY 50,000 500HP 20,000 1stock 15,000 ajlandberg 4,000 alperdel 30,000 andybway 20,000 backingame 42,000 benson3 10,000 Bearish_Bob 7500 beyerjs5 8,000 biggen 50,000 bidcom 35,000 BlakesOma 5,000 bryanmc 23,200 carman 20,000 CashnOut 5,000 casper 6,000 ccdi72 18,000 chuckman 24,000 chs1 6,000 clement 5,300 Cookout7 25,000 compatriot 70,000 chrisc2 4,500 daveyt 40,000 devilsadvocate 5,000 destiny99 10,000 dodger9155 1,000 dqstk 9,500 fannysdad 5,000 farmboy1 65,000 fffats 20,000 flashfushion 2,000 g136035 8,000 george_27 100,000 godfriaux 40,000 jcd83 6,000 jjflash24 15,000 kanuk453 1,000 kingcabrera 150,000 LaunchPad_1999 20,000 larryb34 10,000 lopy22 2000 MAGICIAN 25,000 medic1 500,000 mr_investor_x 10,000 MR_62cents 10,000 mussolini 800,000 nebt 5,800 newair 20,000 omard 21,500 pedal 123,000 pinkisntwell 70,000 player19777 10,000 poseidon65 6,000 quiet1 200,000 razor36 2,000 rdc 280,000 resetime 4,500 rick 25,000 rogerdodger 50,000 rjwebwise 10,000 rubma 20,000 shadowwalker 235,000 shamik1 10,000 smack2 2,000 smuggler5 1,250 ssparsons 100,000 staulker 10,000 stockwiz 6,000 stockwoman 10,000 tempest 20,000 trapper 200,000 truetreasure 6,000 vic99 2,000 wannaberich 165,000 wican 20,000 wrongagain 23,800 xxsniper 7,00 0 zelkid 110,000 8086 The total now stands at 4,133,850 which accounts for 59.0% of the float @ 7,000,000. (as public info would allow). Some larger shareholders think the float is now, 10,000,000 shares, therefore the holdings of the PLATINUM - SUPER RAT PACK IS %41.13 PERCENT. THIS IS HUGE, some investment newsletters have this as a favorite, some mutal fund types are in here. Its goin on a RIDE Ladies, and Gentlemen, START YOUR ENGINES.

To: Jim Bishop who wrote (14360)	11/16/1999 8:02:00 AM
From: Mr Metals	Read Replies (1) \| Respond to of 150070

AND IT'S ONLY 30c CDN...LOR TRADES ON THE MSE AND TSE.. Lorus Therapeutics Inc - Lorus files FDA application for anticancer drug Lorus Therapeutics Inc LOR Shares issued 43,280,001 1999-11-15 close $0.31 Tuesday Nov 16 1999 Mr. Philippe Lacaille reports Lorus Therapeutics has filed an investigational new drug (IND) application with the U.S. Food and Drug Administration for the company's lead antisense drug, GTI 2040. The company reported that GTI 2040 demonstrated exceptionally strong antitumour properties when tested with a wide range of human tumours in animal models, including tumours derived from colon, liver, lung, breast, kidney and ovary. GTI 2040 is one of several anticancer products acquired by Lorus in its recent acquisition of GeneSense Technologies Inc. "Through our recent acquisition of GeneSense, we added a very strong portfolio of anticancer drug candidates," said Philippe G. Lacaille, chief executive officer at Lorus. "GTI 2040 is the lead antisense product that was selected from over 100 different compounds. It was chosen because of its target specificity, outstanding antitumour properties and its excellent safety profile in animals." The company reported that when tested against a broad range of human tumour models, GTI 2040 demonstrated excellent activity in all cases. "GTI 2040 was tested in nine different tumour models and in each case, we saw very good activity. Depending on the tumour model, we saw significant inhibition of tumour growth, disease stabilization and in some cases, dramatic tumour regression," said Dr. Jim Wright, president and chief scientific officer at Lorus. "Independent toxicology, or safety studies carried out in rodents and monkeys predict that this compound is likely to be safe in humans at concentrations that exceed the expected therapeutic doses. A preIND meeting was held with the U.S. FDA last month and the outcome was very positive. We have taken into account their comments and on Nov. 5, we filed an IND application to begin phase I/II clinical trials shortly. We are very excited about the prospects for this product." Antisense technology is an innovative drug discovery method that works at the genetic level to interrupt the process by which disease-causing proteins are produced. Unlike traditional drugs that are designed to interact with protein molecules that support or cause diseases, antisense drugs are designed to inhibit the production of disease-causing proteins. Antisense drugs are designed to treat a wide range of diseases including cancer. They have the potential to be more selective and, as a result, more effective and less toxic than traditional drugs, such as most chemotherapeutic agents. WARNING: The company relies upon litigation protection for "forward-looking" statements. (c) Copyright 1999 Canjex Publishing Ltd. canada-stockwatch.com

To: Jim Bishop who wrote (14360)	11/16/1999 9:34:00 AM
From: RCJIII	Read Replies (1) \| Respond to of 150070

ISRI news- (BSNS WIRE) International Star, Inc. Issues Corporate Update International Star, Inc. Issues Corporate Update Business Editors LAS VEGAS--(BUSINESS WIRE)--Nov. 16, 1999--International Star, Inc. (OTCBB:ISRI): Major Purchase Order -- Exceeds $11,000,000 The Company has received its first purchase order from American Consolidators. The order is to equip 1,000 tractors and 5,000 trailers for their trucks operating out of Los Angeles, California and Las Vegas, Nevada. The gross value of this initial order exceeds $11 million. This significant order gives the company strong initial penetration into the lucrative Los Angeles and Las Vegas markets. This transaction was strongly influenced by Qwiktrack's(R) strong product performance and leasing price point strategies. This is merely an initial purchase order, which may be significantly expanded in the future as dictated by customer need and satisfaction with the product. Sales Financing Qwiktrack is negotiating lease arrangements with American Leasing, LLC of Las Vegas, Nevada. These arrangements will enable Qwiktrack to discount our leasing contracts and operate on a cash flow basis. This will enable The Company to grow without the need for additional capital and unacceptable stock dilution. Further Business Developments Qwiktrack's strategic plan calls for selling approximately 10,000 tractor units and 25,000 trailer units in fiscal 2000. We are currently negotiating distribution with two major entities capable of generating North American sales sufficient to meet our goals. We are also negotiating two major joint venture agreements, one for England and one for the Middle East. If successful, these agreements will add significant additional cash flow from both the buy-in-fees from the Joint Ventures as well as the extra leasing and monitoring income. American Towman Exposition Qwiktrack has been invited by the National Towing Alliance to demonstrate our product on Nov. 19-21, 1999, to the attendees of the Exposition. 22,000 companies will attend representing 200,000 tow operators. This represents a wonderful opportunity for us to show off our product, establish recognition in the industry and cultivate potential sales. Qwiktrack is working with the National Towing Alliance to develop a program for their membership that will provide local and national dispatching, insurance premium reductions, mileage reductions, operating cost reductions and consumer acceptance by providing quicker response time per unit dispatched. Service Qwiktrack is negotiating a contract with a national service provider to install and service our units anywhere in North America. Fully Reporting Status The Company's attorneys and accountants continue moving forward with this time consuming process. We anticipate completing and submitting this filing by Dec. 31, 1999. Qwiktrack Server Computer engineers are progressing nicely with their server beta test procedures. Once successfully tested, the site will be accessible anywhere in the World via the internet. The Qwiktrack.com site will provide the following functions: 1) Real time vehicle/asset tracking demonstrations 2) Sign up procedures/contracts 3) Corporate Updates 4) E Commerce- Credit Card/Automatic Bank withdrawal for leases 5) Complete down loading of customer function performance Conclusions: The Corporate Executive Board is very pleased with our rapid growth and development since shifting our focus to Qwiktrack merely 4 months ago. We are positioning the Company to take full advantage of Qwiktrack's enormous sales opportunities in: 1) The Trucking Sector -- estimated 1.3 million tractors and 5-10 million trailers 2) The Towing Industry -- estimated 200,000 trucks 3) The Auto Industry -- estimated 100 million units 4) Personal Use -- unlimited potential (children, elderly, military, etc.) The above represents merely the North American market. With Qwiktrack's intended international expansion, our opportunities are endless. Reputable industry analysts predict that by the year 2003, almost every vehicle in North America will be equipped with a vehicle location system. We intend to capture significant market share from this trend. Through diligent marketing strategies, quality service, creative financing plans and superior products, we believe we can achieve our goal of becoming an industry leader. Note: Safe harbor for Forward Looking Statements Except for historical information contained herein, the statements in this news release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties that may cause the company's actual results in the future periods to differ materially from forecasted results. These risks and uncertainties include, among other things, volatility of prices, product demand, market compensation, risk inherent in the company's international operations, imprecision of reserve estimates and the company's ability to replace and expand reserves. --30--APS/se* CONTACT: International Star, Inc. Pat Westphal, 702/869-8757 KEYWORD: CALIFORNIA NEVADA INDUSTRY KEYWORD: COMPUTERS/ELECTRONICS AUTOMOTIVE TRANSPORTATION PRODUCT Today's News On The Net - Business Wire's full file on the Internet with Hyperlinks to your home page. URL: businesswire.com * end of story *